Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00102245 · ClinicalTrials.gov registry record

Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes

A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Terminated
Registry status
334
Enrollment target

NCT00102245: Clinical Trial study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

NCT00102245 is a clinical trial that was terminated before completion, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 334 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00102245 was terminated before completion, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

TERMINATED
Registry status
334 participants
Enrollment target

Study Summary

This study will examine blood for factors that may cause or prevent diseases involving iron or red blood cells. Iron is an important nutrient for human health that is needed to produce red blood cells. Red blood cells carry oxygen to body tissues. A better understanding of iron and red blood cells may help lead to better treatment of several diseases including anemia. Patients of all ages with red cell abnormalities in the following categories may be eligible for this study: * Diseases with deficiency, overload or maldistribution of iron * Known red blood cell diseases, such as anemias and hemoglobinopathies * Red blood cell diseases of unknown cause, such as hemolysis of unknown cause * Red blood cell abnormalities with no overt clinical disease, such as hereditary persistence of fetal hemoglobin Participants undergo the following procedures: * Medical history * Physical examination * Standard medical tests related to the individual's iron or red blood cell condition Blood draw for the following purposes: * Testing for syphilis and for the hepatitis B and C, HIV, and HTLV-1viruses, and for a pregnancy test for women who can become pregnant * Research purposes. This blood is analyzed for genes, proteins, sugars, and fat molecules.

Trial Details

FieldValue
Enrollment Target 334 participants
Start Date 2005-01-18
Est. Completion 2017-08-04

Why NCT00102245 stopped before completion

NCT00102245 is an observational study that tracks outcomes without assigning an intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00102245 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00102245 about?

NCT00102245 is a clinical study titled "Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes". This study will examine blood for factors that may cause or prevent diseases involving iron or red blood cells. Iron is an important nutrient for human health that is needed to produce red blood cells. Red blood cells carry oxygen to body tissues. A better understanding of iron and red blood cells m...

What is the current status of trial NCT00102245?

This trial is currently terminated. The enrollment target is 334 participants. The study started on 2005-01-18. Estimated completion is 2017-08-04.

Who is sponsoring clinical trial NCT00102245?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05131672 · 334 participants · NA

    Cast or Operation for Medial Epicondyle Fracture Treatment in Children

  • NCT05131685 · 334 participants · NA

    Distal Radius Interventions for Fracture Treatment

  • NCT05546931 · 334 participants · NA

    Mobile Health Program for Rural Hypertension

  • NCT05722197 · 334 participants · NA

    Assessment of Emotion Regulation Strategies Used When Suicidal

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00102245, the US trial registry maintained by the National Library of Medicine. NCT00102245 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.